After an initial decrease, the PVC burden remained stable over time. All 169 patients underwent baseline Holter monitoring at disease diagnosis; 146, within the first 12 months after diagnosis; 149, 13 to 24 months after diagnosis; 122, 25 to 36 months after diagnosis; 86, 37 to 48 months after diagnosis; and 50, 49 to 60 months after diagnosis.
aP < .001.
bP = .88.